AbbVie and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions.
Johnson & Johnson (NYSE: JNJ) announced today that 23 abstracts featuring new real-world and clinical trial data from across its neuropsychiatry portfolio and pipeline will be presented at the annual ...
The public service campaign comes amid growing concern that AI could be used to confuse Americans about the time, place or manner of voting at their local polling places.
A HEADSET that can be used at home could help cure depression, a study has found. The device, which stimulates the brain using electronic pulses, could have a “significant impact” on ...
Get top local stories in DFW delivered to you every morning ... said of industry colleagues. “You’d lose so many people that you couldn’t put a crew together to frame a house.” Bryan Dunn, an-Arizona ...